| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-20 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-15 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-10 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |